Increasing scrutiny of antipsychotics.
Levin-Epstein
Michael
M
levin-epstein1006@behavioral.net
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D014150:Antipsychotic Agents